Sponsor hub
Burzynski Research Institute clinical trial failures
Review 43 stopped clinical trials from Burzynski Research Institute, including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 1 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OPERATIONAL
- 42
- SAFETY
- 1
Notable sponsors
- Burzynski Research Institute
- 43
Related phases
- Phase II
- 42
- Phase III
- 1
Crawlable stopped-trial records
Open ExploreShowing up to 43 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Phase II Diffuse, Intrinsic Pontine Glioma trial by Burzynski Research Institute. Stop reason: SAFETY.
Clinical Hold
Phase II Ependymoma trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
Slow accrual
Phase II Multiple Myeloma trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
Slow accrual
Phase II Adenocarcinoma of the Esophagus trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
Slow accrual
Phase II Malignant Mesothelioma trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
Withdrawn due to slow enrollment
Phase II Non Hodgkin Lymphoma trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
Slow accrual
Phase II Stage IV Pancreatic Cancer trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
Slow accrual
Phase II Stage IV Melanoma trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
Slow accrual
Phase II Unknown Primary Carcinoma trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
Slow accrual
Phase II Stage IV Lung Cancer trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
Slow accrual
Phase II Stage IV Adrenocortical Carcinoma trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
Slow enrollment
Phase II Low-Grade Astrocytoma, Nos trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
Slow accrual
Phase II Oligodendroglioma, Adult trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
Slow accrual
Phase II High Grade Glioma trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
Slow accrual
Phase II Non-hodgkins Lymphoma trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
slow accrual
Phase II Prostate Cancer trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
Slow accrual
Phase II Waldenstrom Macroglobulinemia trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
No participants enrolled
Phase II Stage IV Non-small Cell Lung Cancer trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
slow accrual
Phase II Non-hodgkins Lymphoma trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
slow accrual
Phase II Stage IV Prostate Cancer trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
No participants enrolled.
Phase II Bronchial Alveolar trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
Slow accrual
Phase II Metastatic Prostate Cancer trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
Slow accrual
Phase II Stage III Ovarian Cancer trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
Slow accrual
Phase II Primary Liver Cancer trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
Slow accrual
Phase II Head and Neck Cancer trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
slow accrual
Phase II Soft Tissue Sarcoma trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
slow accrual
Phase II Cervical Cancer Stage IV trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
slow accrual
Phase II Stomach (Gastric) Cancer trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
slow accrual
Phase II Stage IV Lung Cancer trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
Slow accrual
Phase II Small Intestine Cancer trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
slow accrual
Phase II Primitive Neuroectodermal Tumor trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
slow accrual
Phase II Stage IV Kidney Cancer trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
slow accrual
Phase II Stage IV Breast Cancer trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
slow accrual
Phase II Small Cell Lung Cancer Extensive Stage trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
slow accrual
Phase II Colon Cancer trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
slow accrual
Phase II Neuroblastoma trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
slow accrual
Phase II Stage IV Bladder Cancer trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
slow enrollment
Phase II Stage IV Lung Cancer trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
slow accrual
Phase II Childhood Brain Tumor trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
Slow accrual
Phase II Meningioma trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
Slow accrual
Phase II Rhabdoid Neoplasm of CNS trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
Slow accrual
Phase III Optic Nerve Glioma trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
Withdrawn: study halted prematurely, prior to enrollment of first participant
Phase II CNS Tumor trial by Burzynski Research Institute. Stop reason: OPERATIONAL.
Slow accrual